小任班长的博客 The Chinese bio-specific immunoglobulin made its first public appearance at the Service Trade Fair
The Chinese bio-specific immunoglobulin made its first public appearance at the Service Trade Fair
At the 2020 China International Trade in Services Fair held in Beijing from September 5th to 9th, Sinopharm Sinopharm, which was invited to participate in the public health and epidemic prevention special exhibition area, presented two new inactivated vaccines for the new crown. The identity of "Main Coffee" made a stunning debut for the first time and attracted the attention of the audience.
It is understood that the two COVID-19 inactivated vaccines exhibited at the exhibition have now entered the final phase III clinical trials, and are being carried out intensively in the UAE, Bahrain, Peru, Morocco, Argentina and other countries and regions. The enrolled 50,000 people were vaccinated, and the sample population has now covered 115 countries, and progress in all aspects is leading the world. At the same time, China National Biotech has established high-level biosafety production facilities in two biological products research institutes in Beijing and Wuhan, and the total annual production capacity of the two vaccine production workshops can reach 300 million doses.
In addition, China's bio-specific immunoglobulin, which has played an important role in the prevention and control of the epidemic in Hubei and Wuhan, as well as in the emergency treatment of critically ill patients in Beijing Xinfadi, Urumqi, Xinjiang, etc., is also in the service trade fair. Made its first public appearance on In the context of the continuous deterioration of the new crown pneumonia epidemic situation in many countries around the world, China's biotechnology anti-epidemic achievements have attracted attention.
